Orgenesis Inc. Common Stock
ORGS
ORGS was delisted on the 18th of October, 2024.
22 hedge funds and large institutions have $2.28M invested in Orgenesis Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
5% more funds holding
Funds holding: 21 → 22 (+1)
41% less capital invested
Capital invested by funds: $3.88M → $2.28M (-$1.6M)
71% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$55K |
| 2 |
Prudential Financial
Newark,
New Jersey
|
+$36.4K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$17.8K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$564 |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$320 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$61K |
| 2 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$37K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$10.2K |
| 4 |
Renaissance Technologies
New York
|
-$9.97K |
| 5 |
BlackRock
New York
|
-$3.06K |
ORGS Hedge Fund Activity: Q3 2022 in Review
22 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Orgenesis Inc. Common Stock (ORGS) for Q3 2022, worth a combined $2.28M — down 41% from $3.88M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new ORGS positions and 2 closed out — a net gain of 1 holder — while 2 added to existing stakes and 7 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $55K. The largest seller was D.E. Shaw & Co, exiting entirely with an estimated $61K sold.
- 22 institutional investors held Orgenesis Inc. Common Stock (ORGS) as of Q3 2022, up from 21 in Q2 2022.
- Funds reported $2.28M of Orgenesis Inc. Common Stock stock for Q3 2022, down 41% quarter-over-quarter.
- 3 funds opened new Orgenesis Inc. Common Stock positions in Q3 2022 and 2 closed out, a net change of +1 holder.
- The largest Orgenesis Inc. Common Stock buyer in Q3 2022 was Susquehanna International Group, an estimated $55K added.
- The largest Orgenesis Inc. Common Stock seller in Q3 2022 was D.E. Shaw & Co, an estimated $61K sold.
Based on aggregated 13F filings for Q3 2022.